FDA Approves Cymbalta® For The Management Of Chronic Musculoskeletal Pain
FDA Approves Cymbalta® For The Management Of Chronic Musculoskeletal Pain
Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved Cymbalta® (duloxetine HCl) for the management of chronic musculoskeletal pain. This has been established in studies in patients with chronic low back pain and chronic pain due to osteoarthritis. [...]